Pharming Group N.V. ADR
(PHAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 42,541 | 0 | 54,200 | 0 | 46,617 |
| Cost of Goods | 4,075 | N/A | 2,300 | N/A | 4,877 |
| Gross Profit | 38,466 | N/A | 51,900 | N/A | 41,740 |
| Operating Expenses | 52,204 | 0 | 44,400 | 0 | 39,792 |
| Operating Income | -13,663 | N/A | 7,800 | N/A | 2,825 |
| Other Income | -3,011 | 0 | 1,500 | 0 | 1,408 |
| Pre-tax Income | -16,674 | 0 | 9,300 | 0 | 4,233 |
| Income Tax | -4,466 | N/A | 200 | N/A | 772 |
| Net Income Continuous | -12,208 | N/A | 9,100 | N/A | 3,461 |
| Net Income | $-12,208 | $N/A | $9,100 | $N/A | $3,461 |
| EPS Basic Total Ops | -0.19 | N/A | 0.14 | N/A | 0.05 |
| EPS Basic Continuous Ops | -0.19 | N/A | 0.14 | N/A | 0.05 |
| EPS Diluted Total Ops | -0.19 | N/A | 0.13 | N/A | 0.05 |
| EPS Diluted Continuous Ops | -0.19 | N/A | 0.13 | N/A | 0.05 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.19 | N/A | 0.04 | N/A |
| EBITDA(a) | $-11,357 | $N/A | $7,800 | $N/A | $5,015 |